AstraZeneca Profit Beats Estimates on Cancer, Diabetes Drugs
AstraZeneca Plc’s profit rose more than analysts anticipated last quarter, buoyed by sales of its blockbuster cancer and diabetes drugs.
By Ashleigh Furlong · Bloomberg
AstraZeneca Plc’s profit rose more than analysts anticipated last quarter, buoyed by sales of its blockbuster cancer and diabetes drugs.